Logo

Sema4: Nat Turner, Emily Leproust, Eli Casdin

Feb 10, 2021

Sema4 has appointed three new members to its board of directors, who will take up their posts after the firm has gone public through a planned merger with special purpose acquisition company CM Life Sciences.

The new members are Nat Turner, cofounder and CEO of Flatiron Health; Emily Leproust, cofounder and CEO of Twist Bioscience; and Eli Casdin, founder and chief investment officer of Casdin Capital.

Breaking News
The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.